0001181431-12-026762.txt : 20120501
0001181431-12-026762.hdr.sgml : 20120501
20120501170248
ACCESSION NUMBER: 0001181431-12-026762
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120501
FILED AS OF DATE: 20120501
DATE AS OF CHANGE: 20120501
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CROWLEY Richard
CENTRAL INDEX KEY: 0001352961
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15313
FILM NUMBER: 12801576
MAIL ADDRESS:
STREET 1: IMCLONE SYSTEMS INCORPORATED
STREET 2: 180 VARICK STREET, 6TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000722104
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 133033811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
BUSINESS PHONE: 7324189300
MAIL ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
FORMER COMPANY:
FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP
DATE OF NAME CHANGE: 19920703
4
1
rrd343595.xml
X0305
4
2012-05-01
0
0000722104
SAVIENT PHARMACEUTICALS INC
SVNT
0001352961
CROWLEY Richard
SAVIENT PHARMACEUTICALS, INC.
ONE TOWER CENTER BLVD.
EAST BRUNSWICK
NJ
08816
0
1
0
0
EVP Biopharmaceutical Operatio
Common Stock, $.01 par value per share
2012-05-01
4
S
0
9200
2.35
D
343800
D
These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax withholding obligations in connection with the vesting of restricted stock granted on April 30, 2011.
/s/ Irina Ishak for Richard Crowley
2012-05-01